Business

This French Farmer Is Excited about the Future of CBD

Since the European Union ruled France's ban on CBD to be unconstitutional, there has been a rush to get into cultivating hemp for CBD. Many farmers are enthusiastic about the potential of this new crop, including Jean-Marie Moëllo, who's going it alone as an independent. Here we listen to his story and find out how the former truck driver made the conversion from trucking bitumen to growing hemp.

The French are enthusiastic about cannabis, and one French Farmer, Jean-Marie Moëllo, is one of them. “Living off your products is fantastic!” he exclaims from the middle of his sun-drenched plot where, for two years, he has been growing hemp to produce cannabidiol, or CBD, a legal “light cannabis” whose consumption is exploding in France.

This work environment has not always been his home, however. Jean-Marie Moëllo, 36, drove bitumen trucks for seven years before starting professional retraining in parallel. The bitumen, “it does not smell the same,” smiles the thirty-something French Farmer.

For more news like this, download our free cannabis news app.

The Lure of CBD For a French Farmer

“This market attracts so many people that you have to be in it as soon as possible,” remarks the French Farmer in the middle of his plants.

It was when he came across a Facebook post in 2018 that he thought of changing his profession. So, after an obstacle course, convincing a bank, and attempting to understand the legislation in force, Mr. Moëllo joined the small but growing club of French Farmers cultivating CBD.

“My goal is to harvest 50 kilos of flowers in October, so to earn 50,000 euros,” explains the new farmer, based in Brittany in western France.

According to the hemp union, the number of growers has grown from just 50 in 2018 to around 600 today. And among them, “30 to 40% are neo-farmers”, explains Aurélien Delecroix, the president of the union. “There are still a lot of cannabis enthusiasts in France; we’re not going to hide it: being able to cultivate cannabis legally has given birth to many vocations,” says Mr. Delecroix.

The French Farmer Walks a Fine Line

The main difference between recreational cannabis and CBD, so-called “wellness” or “cannabis light,” is the content of tetrahydrocannabinol (THC), the molecule with psychoactive effects. The threshold not to be exceeded in France is 0.3% THC.

“The regulatory and legal aspect has slowed the development of the number of producers. It must be understood that until November 2020, producers incurred a penalty for drug trafficking”, explains Aurélien Delecroix.

The tipping point, according to him, is the “Kanavape affair,” where an electronic cigarette with oil containing CBD had earned a suspended prison sentence for its creators.

The case went to the Court of Justice of the European Union, which delivered its judgment in November 2020: CBD cannot be considered a narcotic, having “no psychotropic effect or harmful effect on the human health.”

France, forced to respect the principle of the free movement of goods and services, cannot, therefore, prohibit its marketing.

“The Kanavape affair remotivated us and gave us hope,” explains Jean-Marie Moëllo, who nevertheless deplores “the gray areas” concerning the CBD legislation. In December, the government banned the sale of flowers before being reauthorized by the Council of State.

Going it Alone

“It’s difficult to project yourself,” denounces the farmer. “I do as it comes, but if one day the legislation becomes too restrictive, I will get back into trucks, so I’m more like no stress,” he continues.

“For the moment, I am within my rights, and it makes me happy to do good to people,” says Mr. Moëllo, who cites among his clients a man who no longer has an ophthalmic migraine since he consumes his CBD or a woman who suffers less from her osteoarthritis. “I’m not a doctor, but it does the job!” he proclaims proudly.

If he remains cautious while waiting to see how the legislation evolves, Jean-Marie Moëllo is hopeful: “When we see the current economic situation, when we see the number of ailments from which people suffer, I tell myself that CBD has good days ahead of him.”

(Featured image by Pixabay via Pexels)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published by Sciences et Avenir, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions, or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

J. Frank Sigerson

J. Frank Sigerson is a business and financial journalist primarily covering crypto, cannabis, crowdfunding, technology, and marketing. He also writes about the movers and shakers in the stock market, especially in biotech, healthcare, mining, and blockchain. In the past, he has shared his thoughts on IT and design, social media, pop culture, food and wine, TV, film, and music. His works have been published in Investing.com, Equities.com, Seeking Alpha, Mogul, Small Cap Network, CNN, Technology.org, among others.

Recent Posts

Pillar 2 Cannabis Pilot Program to Launch in Germany

Germany is advancing its cannabis policy by launching Pillar 2, which involves five-year pilot projects…

4 days ago

Rolling Papers May Contain Traces of Heavy Metals, Study Finds

A new study has revealed that rolling papers can contain heavy metals and chemical residues…

5 days ago

Bitcoin – The Ideal Payment System for a Thriving Cannabis Industry

Bitcoin could serve as a decentralized, stable alternative for the cannabis industry, promoting financial autonomy…

6 days ago

Medical Cannabis Effectiveness Confirmed By Over 80% of Patients

Over 80% of participants in a German study reported that medical cannabis was effective in…

7 days ago

Japan Saw its CBD Market Explode in 2023

Japan saw its CBD market explode to a value of $173.8 million in 2023, driven…

2 weeks ago

Colorado Residents Can Buy License Plates With Cannabis-Related Slogans

Colorado residents can participate in an auction to purchase unique license plates with cannabis-related phrases,…

2 weeks ago